A Culture-tailored Plant-based Dietary Intervention in Taiwan
NCT07728877 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2026-07-27
Summary
The goal of this pilot randomized crossover feasibility trial is to determine the feasibility of a short-term, culture-tailored, plant-based dietary behavior intervention and examine the preliminary outcomes regarding inflammation and metabolic markers in generally healthy adults. The main questions it aimed to answer were:
Are the trial design and corresponding outcomes, including recruitment rate, retention rate, meal delivery completion, participant satisfaction, and adverse event occurrence feasible for a future definitive study? Are the clinical outcomes were examined as preliminary secondary endpoints able to generate effect size estimates for future study planning?
Participants were:
Randomly allocated to group PBD (plant-based diet)-GD (general diet) or group GD-PBD. Group PBD-GD completed the 2-week PBD stage first, crossed over after the 1-week washout period, then completed the 2-week GD stage. Group GD-PBD followed the reverse sequence.
Instructed to record their daily dietary intake throughout both stages in a mobile food diary application.
Invited to visit the trial venue for the measurements at four time points: before and after each stage.
Conditions
- Healthy
- Dietary Habits
Interventions
- OTHER
-
Plant-Based Diet
Lunch and dinner were provided on workdays according to the assigned dietary stage, as boxed takeout meals prepared by local restaurants or catering companies. Deliveries were scheduled to arrive at the study hospital between 12:00 and 12:30 for lunch and 17:00 and 17:30 for dinner. A research assistant was to coordinate and contact the local restaurants for meal delivery an hour before the planned schedule. Participants were instructed to collect their meals from the research office before 12:30 and 17:30, respectively.
- OTHER
-
General Diet
Lunch and dinner were provided on workdays according to the assigned dietary stage, as boxed takeout meals prepared by local restaurants or catering companies. Deliveries were scheduled to arrive at the study hospital between 12:00 and 12:30 for lunch and 17:00 and 17:30 for dinner. A research assistant was to coordinate and contact the local restaurants for meal delivery an hour before the planned schedule. Participants were instructed to collect their meals from the research office before 12:30 and 17:30, respectively.
Sponsors & Collaborators
-
Tzu Chi University
lead OTHER
Principal Investigators
-
Hui-Chun Chung, PhD · Assistant Professor, School of Nursing, Tzu Chi University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-06-01
- Primary Completion
- 2023-09-30
- Completion
- 2023-09-30
Countries
- Taiwan
Study Locations
More Related Trials
-
Effect of Soy Bread on Markers of Bone Metabolism and Cardiovascular Disease
NCT00366860 ·Status: COMPLETED ·Phase: PHASE1
-
Soybean Based Diets and CVD Risk Factors
NCT00175097 ·Status: COMPLETED ·Phase: NA
-
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
NCT03429920 ·Status: COMPLETED ·Phase: NA
-
Effect of Phytosterols on Nonalcoholic Fatty Liver Disease
NCT01875978 ·Status: COMPLETED ·Phase: NA
-
Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLD
NCT05686174 ·Status: UNKNOWN ·Phase: PHASE1
-
The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes Mellitus
NCT02288585 ·Status: COMPLETED ·Phase: NA
-
Dachundou No Sugar Added Soymilk for Lipid Modulation
NCT07175766 ·Status: COMPLETED ·Phase: NA
-
Effect of Phytosterols Enriched Products Consumption on Carotid Artery Artherosclerotic Plaque
NCT00720720 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Dietary Cholesterol on Plasma Lipids
NCT03698929 ·Status: COMPLETED ·Phase: NA
-
Modulation of the Gut Microbiota and Metabolism in Elderly by Algae Products.
NCT06882941 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study for Evaluating the Safety of a Plant Sterol-enriched Fermented Dairy Product in Japanese Healthy Adults
NCT02278393 ·Status: COMPLETED ·Phase: NA
-
"A Clinical Study for Evaluating the Effect of a Plant Sterol-enriched Fermented Dairy Product on Blood Lipoprotein Profile in Japanese Adults"
NCT02268318 ·Status: COMPLETED ·Phase: NA
-
Long-term Effectiveness Study on Cholesterol-reducing Activity
NCT01521169 ·Status: COMPLETED ·Phase: NA
-
Phospholipid-rich Dairy Extract for Cognitive Function
NCT07011680 ·Status: RECRUITING ·Phase: NA
-
Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers
NCT03118583 ·Status: COMPLETED ·Phase: NA
-
The Effects of Consuming Palm Oil With Different Macronutrient Intakes on Blood Lipids
NCT02922062 ·Status: COMPLETED ·Phase: NA
-
The Effect of 3-Week Consumption of Soya Beverage Enriched With Plant Sterols on Serum LDL-C
NCT02881658 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Sterol-Fortified Low Fat Soy Beverage on Cholesterol Metabolism, Inflammation and Oxidative Status in Humans - Study II
NCT00923403 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Plant Sterols on Cardiovascular Markers, Microbiota and Sterol Metabolism (Cardiofoodsterol)
NCT06481020 ·Status: RECRUITING ·Phase: NA
-
A Clinical Trial to Evaluate the Effects of a Chickpea Pasta on Gut Health, Blood Glucose, and Overall Health
NCT07264465 ·Status: COMPLETED ·Phase: NA
-
Effect of Soymilk Replacement on Anthropometric and Blood Pressure Value
NCT01253876 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Nutritional Counseling Regularity on the Risk of Cardiovascular Diseases
NCT05092087 ·Status: COMPLETED
-
Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness
NCT02180841 ·Status: COMPLETED ·Phase: NA
-
Impact of Consuming Plant Sterols on Endothelial Function and Blood Pressure
NCT03723330 ·Status: COMPLETED ·Phase: NA
-
Vegan vs AHA Diet on Inflammation and Glucometabolic Profile in Patients With CAD
NCT02135939 ·Status: COMPLETED ·Phase: NA